1992
DOI: 10.1016/0278-5846(92)90106-o
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Neurotransmitter changes in early- and late-onset alzheimer-type dementia

Search citation statements

Order By: Relevance

Paper Sections

Select...
34
6
3
0

Citation Types

1
17
0
0

Year Published

Range
1993
1993
2026
2026

Publication Types

Select...
37
4

Relationship

0
41

Authors

Journals

citations

Cited by 41 publications

(18 citation statements)
references

References 12 publications

1
17
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…Aβ in both clinical and preclinical AD, has reports to causes catecholaminergic deficit by escalating AChE enzymatic activity [44,45]. In agreement with the previous findings, the present study also showed significant increase in AChE activity in Aβ infused brains [6][7][8][9][10]. However, the treatment of lupeol was able to significantly decrease AChE activity as reported earlier [17].…”
Section: Conflict Of Interest
supporting
confidence: 91%